Encompass Health (EHC) Set to Announce Quarterly Earnings on Monday

Encompass Health (NYSE:EHC - Get Free Report) is scheduled to be releasing its earnings data after the market closes on Monday, October 28th. Analysts expect Encompass Health to post earnings of $0.94 per share for the quarter. Encompass Health has set its FY24 guidance at $3.97-$4.22 EPS.Investors that wish to register for the company's conference call can do so using this link.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $1.11 EPS for the quarter, beating the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The company had revenue of $1.30 billion for the quarter, compared to analysts' expectations of $1.30 billion. During the same period last year, the firm posted $0.95 earnings per share. Encompass Health's revenue was up 9.6% compared to the same quarter last year. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Stock Performance

NYSE:EHC traded down $1.44 during mid-day trading on Monday, reaching $95.75. The company's stock had a trading volume of 538,801 shares, compared to its average volume of 626,745. The firm's fifty day moving average price is $93.03 and its two-hundred day moving average price is $87.95. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.08. The stock has a market cap of $9.64 billion, a P/E ratio of 25.88, a PEG ratio of 1.43 and a beta of 0.88. Encompass Health has a 12-month low of $57.55 and a 12-month high of $98.74.

Encompass Health announced that its board has approved a share repurchase program on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 5.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.71%. Encompass Health's dividend payout ratio (DPR) is 18.38%.

Analyst Ratings Changes

Several research firms have recently weighed in on EHC. UBS Group increased their price target on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a report on Wednesday, September 25th. Royal Bank of Canada increased their target price on Encompass Health from $95.00 to $105.00 and gave the company an "outperform" rating in a report on Thursday, September 26th. KeyCorp initiated coverage on Encompass Health in a research note on Friday, October 11th. They set an "overweight" rating and a $115.00 price target for the company. Leerink Partnrs upgraded shares of Encompass Health to a "strong-buy" rating in a research note on Wednesday, July 10th. Finally, Truist Financial upped their target price on shares of Encompass Health from $104.00 to $108.00 and gave the company a "buy" rating in a report on Monday, October 14th. Eight research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $104.67.

Insider Buying and Selling at Encompass Health

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the company's stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the sale, the chief financial officer now directly owns 136,227 shares of the company's stock, valued at $11,761,839.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.10% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.